Cost-effectiveness of an Adjuvanted Recombinant Zoster Vaccine in older adults in the United States.
Vaccine
; 36(33): 5037-5045, 2018 08 09.
Article
in En
| MEDLINE
| ID: mdl-30017145
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Herpes Zoster Vaccine
/
Herpes Zoster
Type of study:
Health_economic_evaluation
Aspects:
Patient_preference
Limits:
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
America do norte
Language:
En
Journal:
Vaccine
Year:
2018
Document type:
Article
Country of publication:
Países Bajos